Effects of Off-Pump and On-Pump Coronary-Artery Bypass Grafting at 1 Year
Carregando...
Citações na Scopus
359
Tipo de produção
article
Data de publicação
2013
Editora
MASSACHUSETTS MEDICAL SOC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
LAMY, Andre
DEVEREAUX, P. J.
PRABHAKARAN, Dorairaj
TAGGART, David P.
HU, Shengshou
PAOLASSO, Ernesto
STRAKA, Zbynek
PIEGAS, Leopoldo S.
AKAR, Ahmet Ruchan
JAIN, Anil R.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
NEW ENGLAND JOURNAL OF MEDICINE, v.368, n.13, p.1179-1188, 2013
Resumo
BACKGROUND Previously, we reported that there was no significant difference at 30 days in the rate of a primary composite outcome of death, myocardial infarction, stroke, or new renal failure requiring dialysis between patients who underwent coronary-artery bypass grafting (CABG) performed with a beating-heart technique (off-pump) and those who underwent CABG performed with cardiopulmonary bypass (on-pump). We now report results on quality of life and cognitive function and on clinical outcomes at 1 year. METHODS We enrolled 4752 patients with coronary artery disease who were scheduled to undergo CABG and randomly assigned them to undergo the procedure off-pump or on-pump. Patients were enrolled at 79 centers in 19 countries. We assessed quality of life and cognitive function at discharge, at 30 days, and at 1 year and clinical outcomes at 1 year. RESULTS At 1 year, there was no significant difference in the rate of the primary composite outcome between off-pump and on-pump CABG (12.1% and 13.3%, respectively; hazard ratio with off-pump CABG, 0.91; 95% confidence interval [CI], 0.77 to 1.07; P = 0.24). The rate of the primary outcome was also similar in the two groups in the period between 31 days and 1 year (hazard ratio, 0.79; 95% CI, 0.55 to 1.13; P = 0.19). The rate of repeat coronary revascularization at 1 year was 1.4% in the off-pump group and 0.8% in the on-pump group (hazard ratio, 1.66; 95% CI, 0.95 to 2.89; P = 0.07). There were no significant differences between the two groups at 1 year in measures of quality of life or neurocognitive function. CONCLUSIONS At 1 year after CABG, there was no significant difference between off-pump and on-pump CABG with respect to the primary composite outcome, the rate of repeat coronary revascularization, quality of life, or neurocognitive function. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294.)
Palavras-chave
Referências
- [Anonymous], 2004, N ENGL J MED, V350, P1791
- Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
- Brown PP, 2001, ANN THORAC SURG, V72, pS1009, DOI 10.1016/S0003-4975(01)02937-X
- Devereaux PJ, 2005, BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88
- DHAWAN J, 1995, INT J CARDIOL, V49, P267, DOI 10.1016/0167-5273(95)02315-N
- Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366
- Group TE, 1990, HLTH POLICY, V16, P199, DOI 10.1016/0168-8510(90)90421-9
- Hachinski V, 2007, STROKE, V38, P1118, DOI 10.1161/01.STR.0000259385.54832.e4
- Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47
- Hochstenbach JB, 2001, ARCH PHYS MED REHAB, V82, P1360, DOI 10.1053/apmr.2001.25970
- Houlind K, 2012, CIRCULATION, V125, P2431, DOI 10.1161/CIRCULATIONAHA.111.052571
- Houlind K, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-47
- Kaplan E, 1991, WAIS R NEUROPSYCHOLO
- Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384
- Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388
- Lamy A, 2012, AM HEART J, V163, P1, DOI 10.1016/j.ahj.2011.10.007
- LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281
- Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
- Lip GYH, 1999, POSTGRAD MED J, V75, P463, DOI 10.1136/pgmj.75.886.463
- Makaryus AN, 2005, AM J CARDIOL, V96, P778, DOI 10.1016/j.amjcard.2005.05.018
- Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
- Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
- Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859
- Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
- Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923
- Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
- Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
- Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
- Song HK, 2003, EUR J CARDIO-THORAC, V24, P947, DOI 10.1016/S1010-7940(03)00616-X
- STORANDT M, 1984, ARCH NEUROL-CHICAGO, V41, P497, DOI 10.1001/archneur.1984.04050170043013
- Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
- VANDERLINDEN W, 1980, SURGERY, V87, P258
- YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
- Yusuf S, 1994, LANCET, V344, P446